DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Amphetamine Sulfate is a drug marketed by Amneal Pharms, Aurolife Pharma Llc, Granules Pharms, and Lannett. and is included in four NDAs.
The generic ingredient in AMPHETAMINE SULFATE is amphetamine sulfate. There are fifty-five drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the amphetamine sulfate profile page.
A generic version of AMPHETAMINE SULFATE was launched as amphetamine sulfate by AMNEAL PHARMS on December 14th, 2019.
Recent Clinical Trials for AMPHETAMINE SULFATE
Identify potential brand extensions & 505(b)(2) entrants
|Arbor Pharmaceuticals, Inc.||Phase 3|
|Sarah Morrow||Phase 2/Phase 3|
|Arbor Pharmaceuticals, Inc.||Phase 4|